Search

Polychlorinated biphenyls (PCBs) are typical persistent organic pollutants that have been associated with type 2 diabetes (T2DM) in cohort studies. This review aims to comprehensively assess the molecular mechanisms of PCBs‐induced T2DM. Recent progress has been made in the research of PCBs in liver tissue, adipose tissue, and other tissues. By influencing the function of nuclear receptors, such as the aryl hydrocarbon receptor (AhR), pregnancy X receptor (PXR), and peroxisome proliferator activated receptor γ (PPARγ), as well as the inflammatory response, PCBs disrupt the balance of hepatic glucose and lipid metabolism. This is associated with insulin resistance (IR) in the target organ of insulin. Through androgen receptor (AR), estrogen receptor α/β (ERα/β), and pancreato‐duodenal‐homeobox gene‐1 (PDX‐1), PCBs affect the secretion of insulin and increase blood glucose. Thus, this review is a discussion on the relationship between PCBs exposure and the pathogenesis of T2DM. It is hoped to provide basic concepts for diabetes research and disease treatment. [ABSTRACT FROM AUTHOR]

Increasing carbon dioxide (CO2) promotes photosynthesis and mitigates heat stress‐induced deleterious effects on plants, but the regulatory mechanisms remain largely unknown. Here, we found that tomato (Solanum lycopersicum L.) plants treated with high atmospheric CO2 concentrations (600, 800, and 1000 µmol mol−1) accumulated increased levels of melatonin (N‐acetyl‐5‐methoxy tryptamine) in their leaves and this response is conserved across many plant species, including Arabidopsis, rice, wheat, mustard, cucumber, watermelon, melon, and hot pepper. Elevated CO2 (eCO2; 800 µmol mol−1) caused a 6.8‐fold increase in leaf melatonin content, and eCO2‐induced melatonin biosynthesis preferentially occurred through chloroplast biosynthetic pathways in tomato plants. Crucially, manipulation of endogenous melatonin levels by genetic means affected the eCO2‐induced accumulation of sugar and starch in tomato leaves. Furthermore, net photosynthetic rate, maximum photochemical efficiency of photosystem II, and transcript levels of chloroplast‐ and nuclear‐encoded photosynthetic genes, such as rbcL, rbcS, rbcA, psaD, petB, and atpA, significantly increased in COMT1 overexpressing (COMT1‐OE) tomato plants, but not in melatonin‐deficient comt1 mutants at eCO2 conditions. While eCO2 enhanced plant tolerance to heat stress (42°C) in wild‐type and COMT1‐OE, melatonin deficiency compromised eCO2‐induced thermotolerance in comt1 plants. The expression of heat shock proteins genes increased in COMT1‐OE but not in comt1 plants in response to eCO2 under heat stress. Further analysis revealed that eCO2‐induced thermotolerance was closely linked to the melatonin‐dependent regulation of reactive oxygen species, redox homeostasis, cellular protein protection, and phytohormone metabolism. This study unveiled a crucial mechanism of elevated CO2‐induced thermotolerance in which melatonin acts as an essential endogenous signaling molecule in tomato plants. [ABSTRACT FROM AUTHOR]

Summary: During pregnancy many women may experience negative emotions and sleep disturbances. This systematic review and meta‐analysis was conducted to assess the efficacy of cognitive behavioural therapy for insomnia (CBT‐I) or sleep disturbance in pregnant women. From the earliest available publications to 15 April 2022, seven electronic literature databases were searched: PubMed, Web of Science, Cochrane Library, Embase, Chinese National Knowledge Infrastructure, Wanfang Data, and VIP Database for Chinese Science and Technology Journal. Randomised controlled trials of CBT‐I in pregnant women with insomnia or sleep disorders were included. The methodological bias of the included studies was assessed using the Cochrane risk of bias tool. The meta‐analysis was performed using RevMan 5.4 software. Stata Statistical Software: Release 15 was used for sensitivity analysis and publication bias. We included eight randomised controlled trials involving 743 pregnant women. Meta‐analysis showed that, compared with the control group, CBT‐I significantly improved the Insomnia Severity Index (mean difference [MD] = −4.25, 95% confidence interval [CI, −6.32, −2.19], p < 0.001), The Pittsburgh Sleep Quality Index (MD = −3.30, 95% CI [−4.81, −1.79], p < 0.001), sleep onset latency (standardised mean difference [SMD] = −1.25, 95% CI [−2.01, −0.50], p = 0.001), anxiety (SMD = −0.99, 95% CI [−1.32, −0.67], p < 0.001), and depression (SMD = −0.40, 95% CI [−0.72, −0.07], p = 0.02). No significant differences were found in total sleep time (SMD = 0.31, 95% CI [−0.54, 1.17], p = 0.47) and sleep efficiency (SMD = 0.80, 95% CI [−0.53, 2.13], p = 0.24). CBT‐I significantly improved pregnant women's sleep quality, insomnia severity, depression, and anxiety. This meta‐analysis provides evidence that CBT‐I is valid for insomnia or sleep disturbances during pregnancy. [ABSTRACT FROM AUTHOR]

Conjugated small‐molecule (CSM) phototheranostic agents that operate in the second near‐infrared (NIR‐II) region have garnered significant attention in the field of biomedicine. However, a lack of fluorescence‐emitting ability hinders their use in precise fluorescence imaging (FI)‐guided photothermal therapy (PTT). Herein, a two‐pronged fluorescence intensification strategy—molecular engineering for rational bandgap modulation and lipid‐intercalation to combat fluorescence quenching—is used to develop NIR‐II‐excited ultrabright donor–acceptor–donor‐based (D–A–D)‐based zwitterionic CSM nanoagent for tumor phototheranostics. The molecular engineering strategy produces the NIR‐II‐excited D–A–D‐based zwitterionic fluorophore (BTFQ) that exhibits a high NIR‐II fluorescence quantum yield (QY = 0.65%) in dichloromethane. More importantly, BTFQ complexed with liposome (DMPC) to form the zwitterion–liposome nanoagent (BTFQ/DMPC) shows a negligible loss of QY (0.63%) in aqueous media. Moreover, because BTFQ/DMPC possesses excellent photothermal conversion efficiency (PCE = 30.8%) performance, it can be used to realize efficient in vivo 1064 nm single‐photon high‐resolution NIR‐II FI guided NIR‐II PTT. This study introduces a new avenue for the development of NIR‐II‐excited NIR‐II FI/PTT agents for precise and effective tumor treatment. [ABSTRACT FROM AUTHOR]

To improve bone metastases treatment efficacy, current strategies are focused on the integration of chemotherapy with phototheranostic. However, the success of phototheranostic approaches is hampered by the limited tissue penetration depth of near‐infrared‐I (NIR‐I) light (700–900 nm). In this study, a NIR‐II (1000–1700 nm) excitation phototheranostic (BTZ/Fe2+@BTF/ALD) is presented for NIR‐II fluorescence imaging and NIR‐II photoacoustic imaging‐guided NIR‐II photothermal therapy (PTT), chemotherapy, and chemodynamic therapy (CDT) of breast cancer bone metastases. This phototheranostic is developed by integrating a dopamine‐modified NIR‐II absorbing donor–acceptor–donor small molecule (BBT‐FT‐DA), the boronate anticancer drug bortezomib (BTZ), and Fe2+ ions, as CDT catalysts, into an amphiphilic PEGylated phospholipid modified with the bone‐targeting ligand alendronate. In acidic and hydrogen peroxide (H2O2) over expression tumor microenvironment, the boronate–catechol linkage is cleaved and BTZ and Fe2+ ions are released to initiate the Fenton reaction, that is, chemotherapy and CDT, respectively, are initialized. It is confirmed using the murine 4T1 bone metastasis model that BTZ/Fe2+@BTF/ALD significantly suppresses the progression of tumor cells in the bone tissue via a synergistic NIR‐II PTT/chemotherapy/CDT effect. Overall, this work provides fresh insights to guide the development of NIR‐II phototheranostics for breast cancer bone metastases. [ABSTRACT FROM AUTHOR]